P169 Clinical outcomes in patients (pts) with estrogen receptor (ER)+ stage I breast cancer (BC) and Recurrence Score (RS) 26–30: Real-world data
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-03-01
|
Series: | Breast |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0960977623002862 |
_version_ | 1797869873457528832 |
---|---|
author | O. Rotem I. Peretz M. Leviov I. Kuchuk A. Itay M. Tokar S. Paluch-Shimon O. Maimon R. Yerushalmi K. Drumea E. Evron A. Sonnenblick E. Gal-Yam H. Goldvaser S. Yosef R. Merose A. Bareket-Samish L. Soussan-Gutman S.M. Stemmer |
author_facet | O. Rotem I. Peretz M. Leviov I. Kuchuk A. Itay M. Tokar S. Paluch-Shimon O. Maimon R. Yerushalmi K. Drumea E. Evron A. Sonnenblick E. Gal-Yam H. Goldvaser S. Yosef R. Merose A. Bareket-Samish L. Soussan-Gutman S.M. Stemmer |
author_sort | O. Rotem |
collection | DOAJ |
first_indexed | 2024-04-10T00:19:20Z |
format | Article |
id | doaj.art-efd7777fab664f96b740807f254683ba |
institution | Directory Open Access Journal |
issn | 1532-3080 |
language | English |
last_indexed | 2024-04-10T00:19:20Z |
publishDate | 2023-03-01 |
publisher | Elsevier |
record_format | Article |
series | Breast |
spelling | doaj.art-efd7777fab664f96b740807f254683ba2023-03-16T05:02:28ZengElsevierBreast1532-30802023-03-0168S81S82P169 Clinical outcomes in patients (pts) with estrogen receptor (ER)+ stage I breast cancer (BC) and Recurrence Score (RS) 26–30: Real-world dataO. RotemI. PeretzM. LeviovI. KuchukA. ItayM. TokarS. Paluch-ShimonO. MaimonR. YerushalmiK. DrumeaE. EvronA. SonnenblickE. Gal-YamH. GoldvaserS. YosefR. MeroseA. Bareket-SamishL. Soussan-GutmanS.M. Stemmerhttp://www.sciencedirect.com/science/article/pii/S0960977623002862 |
spellingShingle | O. Rotem I. Peretz M. Leviov I. Kuchuk A. Itay M. Tokar S. Paluch-Shimon O. Maimon R. Yerushalmi K. Drumea E. Evron A. Sonnenblick E. Gal-Yam H. Goldvaser S. Yosef R. Merose A. Bareket-Samish L. Soussan-Gutman S.M. Stemmer P169 Clinical outcomes in patients (pts) with estrogen receptor (ER)+ stage I breast cancer (BC) and Recurrence Score (RS) 26–30: Real-world data Breast |
title | P169 Clinical outcomes in patients (pts) with estrogen receptor (ER)+ stage I breast cancer (BC) and Recurrence Score (RS) 26–30: Real-world data |
title_full | P169 Clinical outcomes in patients (pts) with estrogen receptor (ER)+ stage I breast cancer (BC) and Recurrence Score (RS) 26–30: Real-world data |
title_fullStr | P169 Clinical outcomes in patients (pts) with estrogen receptor (ER)+ stage I breast cancer (BC) and Recurrence Score (RS) 26–30: Real-world data |
title_full_unstemmed | P169 Clinical outcomes in patients (pts) with estrogen receptor (ER)+ stage I breast cancer (BC) and Recurrence Score (RS) 26–30: Real-world data |
title_short | P169 Clinical outcomes in patients (pts) with estrogen receptor (ER)+ stage I breast cancer (BC) and Recurrence Score (RS) 26–30: Real-world data |
title_sort | p169 clinical outcomes in patients pts with estrogen receptor er stage i breast cancer bc and recurrence score rs 26 30 real world data |
url | http://www.sciencedirect.com/science/article/pii/S0960977623002862 |
work_keys_str_mv | AT orotem p169clinicaloutcomesinpatientsptswithestrogenreceptorerstageibreastcancerbcandrecurrencescorers2630realworlddata AT iperetz p169clinicaloutcomesinpatientsptswithestrogenreceptorerstageibreastcancerbcandrecurrencescorers2630realworlddata AT mleviov p169clinicaloutcomesinpatientsptswithestrogenreceptorerstageibreastcancerbcandrecurrencescorers2630realworlddata AT ikuchuk p169clinicaloutcomesinpatientsptswithestrogenreceptorerstageibreastcancerbcandrecurrencescorers2630realworlddata AT aitay p169clinicaloutcomesinpatientsptswithestrogenreceptorerstageibreastcancerbcandrecurrencescorers2630realworlddata AT mtokar p169clinicaloutcomesinpatientsptswithestrogenreceptorerstageibreastcancerbcandrecurrencescorers2630realworlddata AT spaluchshimon p169clinicaloutcomesinpatientsptswithestrogenreceptorerstageibreastcancerbcandrecurrencescorers2630realworlddata AT omaimon p169clinicaloutcomesinpatientsptswithestrogenreceptorerstageibreastcancerbcandrecurrencescorers2630realworlddata AT ryerushalmi p169clinicaloutcomesinpatientsptswithestrogenreceptorerstageibreastcancerbcandrecurrencescorers2630realworlddata AT kdrumea p169clinicaloutcomesinpatientsptswithestrogenreceptorerstageibreastcancerbcandrecurrencescorers2630realworlddata AT eevron p169clinicaloutcomesinpatientsptswithestrogenreceptorerstageibreastcancerbcandrecurrencescorers2630realworlddata AT asonnenblick p169clinicaloutcomesinpatientsptswithestrogenreceptorerstageibreastcancerbcandrecurrencescorers2630realworlddata AT egalyam p169clinicaloutcomesinpatientsptswithestrogenreceptorerstageibreastcancerbcandrecurrencescorers2630realworlddata AT hgoldvaser p169clinicaloutcomesinpatientsptswithestrogenreceptorerstageibreastcancerbcandrecurrencescorers2630realworlddata AT syosef p169clinicaloutcomesinpatientsptswithestrogenreceptorerstageibreastcancerbcandrecurrencescorers2630realworlddata AT rmerose p169clinicaloutcomesinpatientsptswithestrogenreceptorerstageibreastcancerbcandrecurrencescorers2630realworlddata AT abareketsamish p169clinicaloutcomesinpatientsptswithestrogenreceptorerstageibreastcancerbcandrecurrencescorers2630realworlddata AT lsoussangutman p169clinicaloutcomesinpatientsptswithestrogenreceptorerstageibreastcancerbcandrecurrencescorers2630realworlddata AT smstemmer p169clinicaloutcomesinpatientsptswithestrogenreceptorerstageibreastcancerbcandrecurrencescorers2630realworlddata |